These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 8016876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F, Pozzetto U, Romagnoli J, Tondolo E, Silvestri P, Nanni G, Castagneto M.
    Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
    Danilewicz M, Wagrowska-Danilewicz M.
    Pathol Res Pract; 2006 Apr; 202(1):9-15. PubMed ID: 16343799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ, Zimmermann R, Tiefenbacher CP, Braun K, Sack FU, Kübler W.
    J Heart Lung Transplant; 1995 Apr; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [Abstract] [Full Text] [Related]

  • 12. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers.
    Mas V, Maluf D, Archer K, Yanek K, Mas L, King A, Gibney E, Massey D, Cotterell A, Fisher R, Posner M.
    Transplantation; 2007 Feb 27; 83(4):448-57. PubMed ID: 17318078
    [Abstract] [Full Text] [Related]

  • 13. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
    Szeto CC, Chan RW, Lai KB, Szeto CY, Chow KM, Li PK, Lai FM.
    Nephrol Dial Transplant; 2005 Jan 27; 20(1):105-13. PubMed ID: 15561743
    [Abstract] [Full Text] [Related]

  • 14. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
    Teppo AM, Törnroth T, Honkanen E, Grönhagen-Riska C.
    Transplantation; 2003 Jun 27; 75(12):2113-9. PubMed ID: 12829921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.
    Gençtoy G, Kahraman S, Arici M, Altun B, Erdem Y, Bakkaloğlu M, Yasavul U, Turgan C.
    Transplant Proc; 2006 Mar 27; 38(2):521-8. PubMed ID: 16549165
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Significance of early biopsy in pediatric kidney transplantation.
    Ishimura T, Ishida T, Fujisawa M.
    Aktuelle Urol; 2003 Jul 27; 34(4):234-8. PubMed ID: 14566671
    [Abstract] [Full Text] [Related]

  • 20. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
    Peng W, Chen J, Jiang Y, Shou Z, Chen Y, Wang H.
    Nephrology (Carlton); 2008 Feb 27; 13(1):73-9. PubMed ID: 18199108
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.